Mixiii Biomed – Tel Aviv – 23-25 May 2017
Ann Kramer and Rob McKean will attend the 16th annual MIXiii-Biomed conference and exhibition...read more
The Electrospinning Company is a nanofibre innovation and development company that uses the electrospinning process to manufacture nanofibre structures and scaffolds for the biotech industry, and in particular the rapidly emerging stem cell therapy sector. Stem cells require optimum growing conditions both in labs and in humans and, uniquely, the Electrospinning Company is able to offer its customers both a better scaffold for laboratory use in the discovery phase of new stem cell therapies and also a route to then getting those therapies into patients by partnering with customers to develop specialized implantable nanofibre devices.
Associated Fund Rainbow Seed Fund
Sector Medical / Biotechnology
CEO Ann Kramer will talk at the Angels in MedCity – Oxford Information Evening...read more
The Electrospinning Company Announces £650,000 Funding Round Harwell, UK — 26 January 2017 —...read more